-
Stocks Getting Investors Attention: BP p.l.c. (NYSE:BP), JPMorgan Chase (NYSE:JPM), Sarepta Therapeutics (NASDAQ:SRPT), DaVita HealthCare Partners Inc. (NYSE:DVA), BHP Billiton (NYSE:BBL)
BP p.l.c. (NYSE:BP)‘s stock had its “hold” rating reissued by research analysts at Liberum Capital in a report released on Friday. They currently have a $6.87 target price on the stock. Liberum Capital’s price objective points to a potential upside of 15.89% from the stock’s previous close. On Friday shares of BP p.l.c. (NYSE:BP) closed…
-
Why These Are Hot: Ambev S.A. (NYSE:ABEV), PulteGroup (NYSE:PHM), DaVita HealthCare Partners Inc. (NYSE:DVA), America’s Car-Mart Inc. (NASDAQ:CRMT), American International (NYSE:AIG)
Shares of Ambev S.A. (NYSE:ABEV) have earned an average recommendation of “Buy” from the six analysts that are currently covering the company. Three investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. On Friday shares of Ambev S.A. (NYSE:ABEV) closed at $6.53. Company’s EPS…
-
5 Stock in Different Moves: InvenSense (NYSE:INVN), CBS Corporation (NYSE:CBS), Suncor Energy Inc. (NYSE:SU), Tata Motors (NYSE:TTM), DaVita HealthCare Partners (NYSE:DVA)
On January 09, former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed in the United States District Court for the Northern District of California against InvenSense, Inc. (NYSE:INVN)…
-
Investor’s Alert: Gilead Sciences Inc. (NASDAQ:GILD), Yamana Gold (NYSE:AUY), DaVita HealthCare Partners Inc. (NYSE:DVA), ARI Network Services (NASDAQ:ARIS), Hampden Bancorp (NASDAQ:HBNK)
CVS Health announced Monday that it plans to make Gilead Sciences Inc. (NASDAQ:GILD)’ hepatitis C drugs the exclusive option for most of its consumers starting Wednesday. The announcement comes two weeks after Express Scripts, the nation’s largest manager of prescription drug benefits, said it would solely offer AbbVie’s hepatitis C drug, Viekira Pak, beginning Jan.…
-
Stocks Getting Hot: Corning Inc. (NYSE:GLW), ImmunoGen (NASDAQ:IMGN), Fairpoint Communications (NASDAQ:FRP), DaVita HealthCare Partners Inc. (NYSE:DVA), Lannett Company (NYSE:LCI)
Corning (NYSE:GLW) has earned an “A-” credit rating from Morningstar. The investment research firm’s “A-” rating suggests that the company is a low default risk. They also gave their stock a three star rating. Corning Inc. (NYSE:GLW) in last trading activity fell -0.56% to close at $23.19. Company weekly performance is 2.34% while its quarterly…
-
Stocks in news: Celldex Therapeutics (NASDAQ:CLDX), Oracle Corporation (NYSE:ORCL), Insmed Incorporated (NASDAQ:INSM), First Bancorp (NASDAQ:FBNC), DaVita HealthCare Partners Inc. (NYSE:DVA)
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that patient enrollment has been completed in the Company’s Phase 3 ACT IV study of rindopepimut in EGFRvIII positive glioblastoma, an aggressive form of brain cancer. Celldex Therapeutics, Inc. (NASDAQ:CLDX) in last trading activity moved down -6.38% to close at $16.88. Company weekly performance is -8.46% while its quarterly performance…
-
Stock in News: Medivation (NASDAQ:MDVN), JD.com (NASDAQ:JD), DaVita HealthCare Partners Inc. (NYSE:DVA), Akebia Therapeutics (NASDAQ:AKBA), Solar Senior Capital (NASDAQ:SUNS)
Medivation Inc (NASDAQ:MDVN) Director Clarence Patrick Machado sold 1,580 shares of Medivation stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $113.00, for a total value of $178,540.00. Following the transaction, the director now directly owns 31,500 shares in the company, valued at approximately $3,559,500.…
-
Trending Tickers: Idera Pharmaceuticals (NASDAQ:IDRA), Ensco plc (NYSE:ESV), Vodafone Group Plc (ADR) (NASDAQ:VOD), DaVita HealthCare Partners Inc. (NYSE:DVA), Halliburton Company (NYSE:HAL)
Vincent Milano has been appointed CEO of Idera Pharmaceuticals Inc. (NASDAQ:IDRA) almost one year after stepping down as CEO of ViroPharma. Milano left rare disease specialist ViroPharma in January 2014 shortly after the company was acquired by Shire Pharmaceuticals. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) in last trading activity decreased -0.25% to close at $4.06. Company weekly…
-
Hot Stocks: ConocoPhillips (NYSE:COP), SunEdison (NYSE:SUNE), Denbury Resources Inc. (NYSE:DNR), Delta Air Lines (NYSE:DAL), DaVita HealthCare Partners Inc. (NYSE:DVA)
ConocoPhillips (NYSE:COP) has contributed $50,000 a year over the past four years towards wildlife projects as well as youth related projects. The contributions helped water projects throughout the state. ConocoPhillips (NYSE:COP) in last trading activity moved up 2.30% to close at $70.80. Company weekly performance is -1.30% while its quarterly performance stands at -10.46%. ConocoPhillips…
-
Market Movers: DaVita HealthCare Partners Inc. (NYSE:DVA), Cisco Systems (NASDAQ:CSCO), EMCORE Corporation (NASDAQ:EMKR), Sysco Corporation (NYSE:SYY), Outerwall Inc. (NASDAQ:OUTR)
DaVita HealthCare Partners Inc. (NYSE:DVA) announced an expected earnings hit for the third quarter on Thursday — and then CEO Kent Thiry warned the company will face headwinds over the next two years that may cause it to lose income more significantly in its primary business of kidney care. DaVita HealthCare Partners Inc. (NYSE:DVA) in…